The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement
Juan Javier‐Desloges(University of San Diego), Matthew R. Cooperberg(University of California, San Francisco), Thenappan Chandrasekar(University of California, Davis), Michael Daneshvar(University of California, Irvine), Samuel L. Washington(University of California, San Francisco), Aditya Bagrodia(University of California San Diego), Wayne Brisbane(University of California, Los Angeles), Gregory Gin(University of California, Irvine), Marc Dall’Era(University of California, Davis), Hao G. Nguyen(University of California, Davis), Christopher J. Kane(University of California San Diego), Leonard S. Marks(Urological Research Foundation), Karim Chamie(University of California, Los Angeles)
Cited by 23
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Prostate Cancer, Version 1.2016
|Journal of the National Comprehensive Cancer Network|2016|656
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
|The Journal of Urology|2022|462
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389